Developer docs
API playgroundTry for free, no card

Search company profiles

Vireo Health

Full company profile

uuid0004mfq

Namestring
Vireo Health
Legal namestring
Vireo Health LLC
Company typeenum
Public
Founded yearint
2004
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersMinneapolis, United States
HQ citystring
Minneapolis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis products, cannabis dispensary operations, cannabis cultivation manufacturing, cannabis vape cartridges, multi-state cannabis operator
Industry3 codes
1Medical Cannabis Dispensaries
CodeCRANAFABPrimaryYes
2Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail)
CodeCRANAFAGPrimaryNo
3Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
CodeCRANAFAIPrimaryNo
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Health and Personal Care Retailers456
  • Pharmacies and Drug Retailers456110
SIC code2 codes
  • Retail-Drug Stores And Proprietary Stores5912
  • Pharmaceutical Preparations2834
Product category
Medical Cannabis Retail and Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Retail Cannabis Sales
TypeTransaction Fee
Description

Direct-to-patient sales through company-owned Green Goods and Vireo retail dispensaries. Products include cannabis flower, vape cartridges, capsules, oils, and other cannabis-derived medical products.

vireohealth.com
2Third-Party Distribution
TypeTransaction Fee
Description

Products distributed through third-party owned dispensaries in Arizona, Maryland, and New York.

vireohealth.com
3Home Delivery
TypeTransaction Fee
Description

Medical marijuana delivery service in New York covering NYC, Westchester, Rockland, Nassau, and parts of Suffolk County.

vireohealth.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Marketing or Sales, Supply Chain, Technology or R&D, Infrastructure
Pricing details1 tier
1Medical cannabis products available by patient certification
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products vary by state. Minnesota recently added flower to medical program, reducing costs compared to processed products.

vireohealth.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1Hi*AF
Description

Higher ABV hemp-derived beverages launched in Minnesota to seed adult-use brands.

vireohealth.com
+10 more records
Core offering1 text field

Vireo Health cultivates, manufactures, and sells medical and adult-use cannabis products including cannabis flower, premium strain-specific vape cartridges (Vireo Selects with 80%+ THC), capsules, oral solutions, and pharmaceutical-grade extracts. These products are distributed primarily through company-owned retail dispensaries (Green Goods in Minnesota and Maryland; Vireo in New York), third-party dispensaries in Arizona, Maryland, and New York, and home delivery in New York. Physician-supervised patient consultations and pharmacist-led product selection support the retail experience.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Q3 2024 revenue of $22.4 million excluding discontinued operations and NY, increased 6.2% year-over-year
+1 more record
Product overview1 text field

Vireo Health is a physician-founded, physician-led cannabis company offering medical marijuana products and dispensary services. The company operates retail dispensaries under two primary brands: Vireo Health (medical dispensaries in New York) and Green Goods (medical and adult-use dispensaries in Maryland and Minnesota). The product portfolio includes the Vireo Spectrum platform (color-coded product lines matching products to patient conditions), Vireo Selects premium strain-specific vape cartridges (80%+ THC), and multiple sub-brands including Hi*AF, HiColor, HiRoller, Boundary Waters, Kings & Queens, 1937, Small A$$ Buds, Simple, and Dr. Westwater. The company also offers a proprietary Arches technology platform for omnichannel ecommerce and delivery operations. Products are distributed through company-owned dispensaries and third-party retail locations across Arizona, Maryland, and New York.

Product and service2 records
1Vireo Health Dispensary
CategoryRetail Dispensary
Description

Physician-founded medical cannabis dispensary brand operating in New York, providing cannabis-based capsules, oral solutions, vaporization cartridges, and vaporization oils staffed by physicians, pharmacists, scientists, and horticulturalists.

2Green Goods Dispensary
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-06
Description

Strategic partnership where Ace will assume 51% ownership in Vireo Health of New York LLC, establishing what is expected to become New York's first minority-owned and first scaled social equity operator. The partnership combines Ace's local leadership and community credibility with Vireo's decade-long operational platform built through regulated medical cannabis operations since 2014.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-22
Description

Acquisition of 17 retail dispensaries and properties in Colorado for approximately $49 million in subordinate voting shares. Transaction will expand Vireo's adult-use retail footprint in Colorado to 41 total active dispensaries, expected to close H1 2026.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-18
Description

Acquisition target in Missouri - one of the largest independent operators in the state's adult-use cannabis market with 11 retail stores in the St. Louis area and one in Kansas City. Total facility size of 90,000 square feet. Deal valued at 4.175x 2024 Reference EBITDA of $31M.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-18
Description

Acquisition target in Nevada - consistently solid operator in Nevada's mature cannabis market with 9 retail dispensaries strategically situated in Southern Nevada near Utah border. Total facility size of 54,000 square feet. Deal valued at 4.175x 2024 Reference EBITDA of $31M.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-18
Description

Acquisition target in Utah - dominant player in Utah's medical market with large delivery operation covering 99% of Utah's medical patient population from one retail location. Total facility size of 22,500 square feet plus outdoor capacity. Deal valued at 4.175x 2024 Reference EBITDA of $16M. Developer of Arches platform.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-18
Description

Acquisition target in Florida - Florida's only family-owned and operated cannabis company, quality-first cultivator with licensing deals with leading west coast brands. 10 active retail dispensaries expanding to 14 by Q1 2025. Total facility size of 120,000 square feet including cultivation. Deal valued at approximately 5.4x Reference EBITDA of $28.3M.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-04-19
Description

Partnership with 501(c)(3) nonprofit dedicated to cannabis-related criminal justice reform. Supports efforts to release cannabis prisoners and provides re-entry assistance through micro grants, computer donations, and fair chance hiring programs.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-01-14
Description

Founding member of Green Flower Institute offering standardized cannabis industry education and professional credential programs for dispensary associates, cultivation technicians, and manufacturing agents. Chief Medical Officer Dr. Stephen Dahmer serves on GFI steering committee.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public MSO with vertically integrated dispensary, cultivation, and processing operations across the US. Comparable in physician/medical positioning, broad state footprint, and aggressive M&A growth strategy.

TypeDirect peer
Description

Public MSO with wholesale, retail, and brand portfolio across multiple states. Comparable through its Columbia Care acquisition and similar multi-state consolidation strategy targeting high-population states.

TypeDirect peer
Description

Multi-state cannabis operator with dispensaries in limited-license states including Florida, where Vireo is acquiring The Flowery. Comparable in adult-use and medical dispensary operations, and similar EBITDA-driven M&A targets.

TypeDirect peer
Description

Multi-state cannabis operator with dispensaries, cultivation, and branded products in several Northeast and Midwest states overlapping Vireo's footprint. Comparable as a smaller MSO pursuing geographic and brand expansion.

TypeDirect peer
Description

Multi-state cannabis operator with significant Northeast footprint overlapping Vireo's NY geography. Comparable in physician-supervised dispensary model and patient/caregiver demographic focus.

TypeDirect peer
Description

Nevada-focused cannabis operator with flagship Las Vegas dispensary. Comparable because Deep Roots Harvest (Vireo's pending Nevada acquisition) directly competes in the same mature Nevada retail market.

TypeDirect peer
Description

Multi-state cannabis operator with retail and cultivation footprint in limited-license states including Florida and Massachusetts. Comparable in regional MSO scale, regulated medical/retail dispensary model, and recovery-driven balance-sheet posture.

TypeDirect peer
Description

Multi-state cannabis operator with branded retail and consumer-products presence. Comparable in dispensary-led go-to-market, multi-state expansion through acquisition, and focus on branded consumer products.

TypeDirect peer
Description

Vertically integrated cannabis MSO operating dispensaries and cultivation across multiple states. Directly comparable in retail-led model, geographic expansion via M&A, and medical/adult-use dual exposure.

TypeDirect peer
Description

Largest US multi-state cannabis operator with retail dispensaries, cultivation, and processing across numerous states. Directly comparable in product mix (flower, vapes, extracts), pharmacist-supervised dispensary model, and multi-state expansion strategy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles18 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vireo Health

Medical Cannabis Retail and Manufacturingvireohealth.com/ny

Vireo Health firmographics

Firmographics
Name
Vireo Health
Legal name
Vireo Health LLC
Website
https://vireohealth.com/ny/
Company type
Public
Founded year
2004
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

Vireo Health industry classification

Industry
Product category
Medical Cannabis Retail and Manufacturing
NAICS
Medicinal and Botanical Manufacturing (325411), Health and Personal Care Retailers (456), Pharmacies and Drug Retailers (456110)
SIC
Retail-Drug Stores And Proprietary Stores (5912), Pharmaceutical Preparations (2834)
akta.pro primary industry
Medical Cannabis Dispensaries (CRANAFAB)
akta.pro secondary industries
Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG), Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

Keywords

  • Medical cannabis products
  • Cannabis dispensary operations
  • Cannabis cultivation manufacturing
  • Cannabis vape cartridges
  • Multi-state cannabis operator

Where Vireo Health is headquartered

Location

Headquarters

HQ city
Minneapolis
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Vireo Health business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Marketing or Sales, Supply Chain, Technology or R&D, Infrastructure

Revenue model

  1. Retail Cannabis Sales: Direct-to-patient sales through company-owned Green Goods and Vireo retail dispensaries. Products include cannabis flower, vape cartridges, capsules, oils, and other cannabis-derived medical products.
  2. Third-Party Distribution: Products distributed through third-party owned dispensaries in Arizona, Maryland, and New York.
  3. Home Delivery: Medical marijuana delivery service in New York covering NYC, Westchester, Rockland, Nassau, and parts of Suffolk County.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goMedical cannabis products available by patient certification

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Vireo Health product offering

Product offering

Core offering

Vireo Health cultivates, manufactures, and sells medical and adult-use cannabis products including cannabis flower, premium strain-specific vape cartridges (Vireo Selects with 80%+ THC), capsules, oral solutions, and pharmaceutical-grade extracts. These products are distributed primarily through company-owned retail dispensaries (Green Goods in Minnesota and Maryland; Vireo in New York), third-party dispensaries in Arizona, Maryland, and New York, and home delivery in New York. Physician-supervised patient consultations and pharmacist-led product selection support the retail experience.

Product overview

Vireo Health is a physician-founded, physician-led cannabis company offering medical marijuana products and dispensary services. The company operates retail dispensaries under two primary brands: Vireo Health (medical dispensaries in New York) and Green Goods (medical and adult-use dispensaries in Maryland and Minnesota). The product portfolio includes the Vireo Spectrum platform (color-coded product lines matching products to patient conditions), Vireo Selects premium strain-specific vape cartridges (80%+ THC), and multiple sub-brands including Hi*AF, HiColor, HiRoller, Boundary Waters, Kings & Queens, 1937, Small A$$ Buds, Simple, and Dr. Westwater. The company also offers a proprietary Arches technology platform for omnichannel ecommerce and delivery operations. Products are distributed through company-owned dispensaries and third-party retail locations across Arizona, Maryland, and New York.

Differentiator

Problem solved

Functional benefit

Brands

  • Hi*AF: Higher ABV hemp-derived beverages launched in Minnesota to seed adult-use brands.
  • HiColor
  • HiRoller
  • Boundary Waters
  • Kings & Queens
  • 1937
  • Small A$$ Buds
  • Simple
  • Dr. Westwater
  • Arches
  • Vireo Selects

Products and services

  • Vireo Health Dispensary Physician-founded medical cannabis dispensary brand operating in New York, providing cannabis-based capsules, oral solutions, vaporization cartridges, and vaporization oils staffed by physicians, pharmacists, scientists, and horticulturalists.
  • Green Goods Dispensary

Quantifiable outcome

  • Q3 2024 revenue of $22.4 million excluding discontinued operations and NY, increased 6.2% year-over-year
  • +1 more outcomes

Companies that use Vireo Health

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Vireo Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Vireo Health partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

  • Ace Venture of NY LLCflagshipStrategic or Co-development Partner · 6 April 2026Strategic partnership where Ace will assume 51% ownership in Vireo Health of New York LLC, establishing what is expected to become New York's first minority-owned and first scaled social equity operator. The partnership combines Ace's local leadership and community credibility with Vireo's decade-long operational platform built through regulated medical cannabis operations since 2014.
  • PharmaCann Inc.coreStrategic or Co-development Partner · 22 December 2025Acquisition of 17 retail dispensaries and properties in Colorado for approximately $49 million in subordinate voting shares. Transaction will expand Vireo's adult-use retail footprint in Colorado to 41 total active dispensaries, expected to close H1 2026.
  • Proper BrandscoreStrategic or Co-development Partner · 18 December 2024Acquisition target in Missouri - one of the largest independent operators in the state's adult-use cannabis market with 11 retail stores in the St. Louis area and one in Kansas City. Total facility size of 90,000 square feet. Deal valued at 4.175x 2024 Reference EBITDA of $31M.
  • Deep Roots HarvestcoreStrategic or Co-development Partner · 18 December 2024Acquisition target in Nevada - consistently solid operator in Nevada's mature cannabis market with 9 retail dispensaries strategically situated in Southern Nevada near Utah border. Total facility size of 54,000 square feet. Deal valued at 4.175x 2024 Reference EBITDA of $31M.
  • WholesomeCo CannabiscoreStrategic or Co-development Partner · 18 December 2024Acquisition target in Utah - dominant player in Utah's medical market with large delivery operation covering 99% of Utah's medical patient population from one retail location. Total facility size of 22,500 square feet plus outdoor capacity. Deal valued at 4.175x 2024 Reference EBITDA of $16M. Developer of Arches platform.
  • The FlowerycoreStrategic or Co-development Partner · 18 December 2024Acquisition target in Florida - Florida's only family-owned and operated cannabis company, quality-first cultivator with licensing deals with leading west coast brands. 10 active retail dispensaries expanding to 14 by Q1 2025. Total facility size of 120,000 square feet including cultivation. Deal valued at approximately 5.4x Reference EBITDA of $28.3M.
  • Last Prisoner ProjectminorStrategic or Co-development Partner · 19 April 2022Partnership with 501(c)(3) nonprofit dedicated to cannabis-related criminal justice reform. Supports efforts to release cannabis prisoners and provides re-entry assistance through micro grants, computer donations, and fair chance hiring programs.
  • Green Flower InstituteminorStrategic or Co-development Partner · 14 January 2022Founding member of Green Flower Institute offering standardized cannabis industry education and professional credential programs for dispensary associates, cultivation technicians, and manufacturing agents. Chief Medical Officer Dr. Stephen Dahmer serves on GFI steering committee.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

Vireo Health competitors and assessment

Company assessment

Direct peers

  • Trulieve Cannabis: Public MSO with vertically integrated dispensary, cultivation, and processing operations across the US. Comparable in physician/medical positioning, broad state footprint, and aggressive M&A growth strategy.
  • Cresco Labs: Public MSO with wholesale, retail, and brand portfolio across multiple states. Comparable through its Columbia Care acquisition and similar multi-state consolidation strategy targeting high-population states.
  • Ayr Wellness: Multi-state cannabis operator with dispensaries in limited-license states including Florida, where Vireo is acquiring The Flowery. Comparable in adult-use and medical dispensary operations, and similar EBITDA-driven M&A targets.
  • MariMed: Multi-state cannabis operator with dispensaries, cultivation, and branded products in several Northeast and Midwest states overlapping Vireo's footprint. Comparable as a smaller MSO pursuing geographic and brand expansion.
  • Acreage Holdings: Multi-state cannabis operator with significant Northeast footprint overlapping Vireo's NY geography. Comparable in physician-supervised dispensary model and patient/caregiver demographic focus.
  • Planet 13 Holdings: Nevada-focused cannabis operator with flagship Las Vegas dispensary. Comparable because Deep Roots Harvest (Vireo's pending Nevada acquisition) directly competes in the same mature Nevada retail market.
  • iAnthus Capital Holdings: Multi-state cannabis operator with retail and cultivation footprint in limited-license states including Florida and Massachusetts. Comparable in regional MSO scale, regulated medical/retail dispensary model, and recovery-driven balance-sheet posture.
  • Green Thumb Industries: Multi-state cannabis operator with branded retail and consumer-products presence. Comparable in dispensary-led go-to-market, multi-state expansion through acquisition, and focus on branded consumer products.
  • Verano Holdings: Vertically integrated cannabis MSO operating dispensaries and cultivation across multiple states. Directly comparable in retail-led model, geographic expansion via M&A, and medical/adult-use dual exposure.
  • Curaleaf Holdings: Largest US multi-state cannabis operator with retail dispensaries, cultivation, and processing across numerous states. Directly comparable in product mix (flower, vapes, extracts), pharmacist-supervised dispensary model, and multi-state expansion strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Vireo Health social profiles

Digital presence

Vireo Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vireo Health leadership team

Management profile

Number of profiles

Profiles18 records

Vireo Health subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Vireo Health funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vireo Health M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vireo Health

What does Vireo Health do?

Vireo Health cultivates, manufactures, and sells medical and adult-use cannabis products including cannabis flower, premium strain-specific vape cartridges (Vireo Selects with 80%+ THC), capsules, oral solutions, and pharmaceutical-grade extracts. These products are distributed primarily through company-owned retail dispensaries (Green Goods in Minnesota and Maryland; Vireo in New York), third-party dispensaries in Arizona, Maryland, and New York, and home delivery in New York. Physician-supervised patient consultations and pharmacist-led product selection support the retail experience.

Is Vireo Health a public or private company?

Vireo Health is a public company. It is classified as public and is currently operating.

When was Vireo Health founded?

Vireo Health was founded in 2004. It employs 501 to 1,000 people.

Where is Vireo Health based?

Vireo Health is headquartered in Minneapolis, United States, in the North America region.

How does Vireo Health make money?

Three revenue lines are on record. Retail Cannabis Sales are the primary driver. The others are third-Party Distribution and home Delivery.

Who are Vireo Health's main competitors?

Direct peers on record are Trulieve Cannabis, Cresco Labs, Ayr Wellness, MariMed, Acreage Holdings, Planet 13 Holdings, iAnthus Capital Holdings, Green Thumb Industries, Verano Holdings and Curaleaf Holdings.

Does Vireo Health have an API?

No public API is recorded for Vireo Health.

What industry is Vireo Health in?

Vireo Health's product category is Medical Cannabis Retail and Manufacturing. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries, with a secondary code of CRANAFAG, Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail). Its NAICS code is 325411 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Fresh ToastBig Change in the Cannabis IndustryVireo Health acquired Planet 13, combining two cannabis operators to strengthen their footprint in Nevada, Florida, and Illinois. The deal reflects a shift toward disciplined consolidation amid pricing pressures and regulatory hurdles. The combined company aims to improve efficiency and position for federal reform.PR NewswireACE Venture Completes 51% Acquisition of Vireo Health New York, Uniting Corporate Infrastructure With Cultural Vision and Launching Boukét as New York's Premier Cannabis Lifestyle BrandACE Venture completed its 51% acquisition of Vireo Health of New York, launching Boukét as its flagship cannabis lifestyle brand. The brand, available at select New York dispensaries, plans broader expansion across retail, experiential, and digital channels later in 2026.Stock TitanVireo to cede 51% of New York unit to AceVireo Growth Inc. announced a strategic partnership with Ace Venture of NY, LLC, under which Ace will assume a 51% ownership interest in Vireo Health of New York, establishing what is expected to become New York's first minority-owned vertically integrated medical cannabis operator. The transaction creates a majority social equity-owned platform while allowing Vireo to retain operational support responsibilities for the cultivation, manufacturing, and retail infrastructure it has built since 2014. Vireo CEO John Mazarakis and Ace founder Steven Acevedo will serve on the board of managers of Vireo NY.ForbesCannabis M&A Didn’t Vanish. It’s Just Not Happening In PublicA analysis of the cannabis industry's M&A landscape argues that while public multistate operators remain constrained by low valuations and minimal cash consideration, consolidation is actively occurring through private operators and credit-led structures rather than headline mergers. Mitchell Osak's analysis suggests a true M&A "tsunami" is unlikely in 2026 given that fewer than 5% of licence exits between 2022 and 2025 were tied to M&A, with most occurring through closures and inactivations. Seth Yakatan counters that consolidation is already underway, pointing to Vireo Health as a model: the company raised approximately $75 million in equity and announced acquisitions totaling roughly $397 million in consideration, largely structured as stock with performance-based earnouts, including an all-stock acquisition of Eaze valued at about $47 million.TracxnTop Companies in Cannabis Based Nutraceuticals (Oct, 2025)Over the past decade, an average of 151 new companies in cannabis-based nutraceuticals have been launched each year, with notable founders from institutions like the University of California, Berkeley. The article highlights several top startups in the sector, including Better Choice Company, Puresport, Kradle, and Vireo Health, detailing their products, founding years, and funding information.TracxnTop Companies in Cannabis Based Nutraceuticals (Jan, 2025)The article presents a ranked list of top startups in the cannabis-based nutraceuticals sector, including Demetrix, Vireo Health, Equilibria, and Nutritional High. It provides specific operational details for these entities, such as their founding years, locations, funding stages, and total capital raised. The text also notes that an average of 142 new companies in this niche are launched annually.Minnesota House of RepresentativesMedical Cannabis ManufacturersLeafLine Labs and Minnesota Medical Solutions (now Vireo Health/Green Goods) were selected as registered medical cannabis manufacturers in Minnesota. These manufacturers are required to contract with approved independent laboratories for product testing.GlobeNewswireCORRECTION - ACE Venture Enterprises, Inc. Announces Planned Acquisition of Vireo Health of New York from Goodness Growth HoldingsACE Venture Enterprises and Goodness Growth Holdings executed a binding term sheet to acquire Vireo Health of New York, pending regulatory approval. The purchase price is $3-5 million, with a $20 million investment for the Johnstown campus and a 15% net profit share for Goodness Growth. Closing is expected by June 30, 2024.GlobeNewswireACE Venture Enterprises, Inc. Announces Planned Acquisition of Vireo Health of New York from Goodness Growth HoldingsACE Venture Enterprises and Goodness Growth Holdings executed a binding term sheet to acquire Vireo Health of New York, pending regulatory approval. The purchase price is $3-5 million, with a $20 million investment for the Johnstown campus and a 15% net profit share for Goodness Growth. Closing is expected by June 30, 2024.PR Newswire100 Million Ways Hosted Its First Dinner Gala at The Boathouse in Central ParkThe 100 Million Ways Foundation held its first dinner gala on September 21, 2022, at Manhattan's Boathouse in Central Park, raising nearly $100,000 to support its harm reduction programs for individuals with opioid use challenges. The event featured speakers from healthcare companies including Vireo Health, OnTracka, Wesana, and Columbia Care, and was sponsored by firms such as Abstrax, Foley Hoag, Cresco Labs, and Columbia Care. Proceeds will fund immediate implementation of the SOAR Sessions drop-in program and the development of two 2023 programs focused on psychedelics-as-medicine research and contingency management for sobriety.